AI assistant
Axogen, Inc. — Director's Dealing 2021
May 21, 2021
32414_dirs_2021-05-21_cafb4e68-4b93-41c9-b4a2-2e5408a4eabf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2021-05-19
Reporting Person: NEELS GUIDO J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-19 | Common Stock | M | 25000 | $3.80 | Acquired | 27591 | Direct |
| 2021-05-19 | Common Stock | M | 15000 | $5.09 | Acquired | 42591 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-05-19 | Stock Option (right to buy) | $3.8 | M | 25000 | Disposed | 2022-08-26 | Common Stock (25000.0) | Direct |
| 2021-05-19 | Stock Option (right to purchase) | $5.09 | M | 15000 | Disposed | 2022-12-29 | Common Stock (15000.0) | Direct |
Footnotes
F1: The Reporting Person has elected to exercise and hold the shares at this time.
F2: All shares of Common Stock underlying the employee stock option became fully vested on August 26, 2017 (2 years from the option grant date) based upon a vesting schedule whereby 12.5% of total shares vested at the end of each fiscal quarter.
F3: All shares of Common Stock underlying the employee stock option became fully vested on December 31, 2016 (1 year from the option grant date) based upon a vesting schedule whereby 25% of the total shares vested at the end of each fiscal quarter.